# US Venous Blood Collection Devices Market > US Venous Blood Collection Devices Market Research Report By Type (Blood Collection Tubes, Lancet), By Material (Plastic, Glass, Steel), By Application (Vein Blood Gas Sampling) and By End User (Hospitals, Blood Donation Centers) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 4.06% - **2024:** $ 1,519 Million - **2025:** $ 1,580.67 Million - **2035:** $ 2,353.22 Million - **Key Players:** Becton Dickinson and Company (US), Terumo Corporation (JP), F. Hoffmann-La Roche Ltd (CH), Greiner Bio-One International GmbH (AT), Cardinal Health Inc. (US), Smiths Medical (US), Sarstedt AG & Co. (DE), Medtronic plc (IE) **Report ID:** MRFR/MED/18011-HCR · **Pages:** 100 · **Author:** Garvit Vyas · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-venous-blood-collection-devices-market-19558 --- ## Market Summary ## **US Venous Blood Collection Devices Market Overview** As per MRFR analysis, the US Venous Blood Collection Devices Market Size was estimated at 1.45 (USD Billion) in 2023. The US Venous Blood Collection Devices Market Industry is expected to grow from 1.6(USD Billion) in 2024 to 2.5 (USD Billion) by 2035. The US Venous Blood Collection Devices Market CAGR (growth rate) is expected to be around 4.141% during the forecast period (2025 - 2035). ### **Key US Venous Blood Collection Devices Market Trends Highlighted** The US Venous Blood Collection Devices Market is witnessing notable trends shaped by advancements in technology and a growing emphasis on patient safety. Increased demand for efficient and less painful blood collection methods is driving healthcare providers to adopt new devices that enhance the overall patient experience. More hospitals and laboratories are focusing on innovative materials and designs, leading to the development of devices that minimize the risk of contamination and ensure proper blood draw techniques. Key market drivers include the rising prevalence of chronic diseases and an increased number of diagnostic tests being performed, which contributes to a heightened need for reliable venous blood collection methods. Moreover, regulatory support aimed at improving healthcare systems further stimulates the market for these devices. The US healthcare landscape is continually evolving, emphasizing quality care and safety, thereby creating opportunities for innovative blood collection solutions that align with these priorities. Recently, there has been a noticeable shift towards the integration of digital tools in the blood collection process. The use of digital platforms and automation is improving workflow efficiency, allowing for faster turnaround times in diagnostics. This trend is reflected in the growing utilization of advanced blood collection systems that incorporate features such as RFID tracking to enhance inventory management and tracking of samples. Additionally, with the focus on home healthcare, there is a significant opportunity to explore portable and user-friendly blood collection devices that can be used outside traditional healthcare facilities. As the US population ages and seeks convenience in healthcare, these devices can cater to the evolving needs of patients. The market continues to adapt, driven by both technological advancements and the quest for improved healthcare outcomes. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **US Venous Blood Collection Devices Market Drivers** #### **Increasing Prevalence of Chronic Diseases** The growing prevalence of chronic diseases such as diabetes and cardiovascular diseases is significantly driving the US [Venous Blood Collection Devices](../../../reports/venous-blood-collection-devices-market-5761) Market Industry. The Centers for Disease Control and Prevention (CDC) reports that approximately 34.2 million Americans, or 10.5% of the population, have diabetes, a disease that often requires routine blood tests for management. Additionally, around 795,000 Americans suffer a stroke each year, leading to heightened blood testing needs. Such statistics suggest that the demand for venous blood collection devices is expected to increase as healthcare providers adopt more advanced diagnostic procedures. Leading organizations like the American Diabetes Association and American Heart Association emphasize the importance of regular monitoring for these chronic conditions, thereby boosting the market for blood collection devices. This growth trend aligns with the projected increase in total spending on healthcare in the United States, representing a crucial driver for the market. #### **Advancements in Blood Collection Technology** Technological advancements in blood collection devices contribute profoundly to the growth of the US Venous Blood Collection Devices Market Industry. Innovations such as safety-engineered devices, which minimize the risk of needlestick injuries, have become increasingly prevalent. According to the National Institute for Occupational Safety and Health (NIOSH), needlestick injuries among healthcare workers can exceed 1,000,000 annually, fostering the need for safer blood collection systems. Companies like BD (Becton, Dickinson and Company) are at the forefront of developing these safety-engineered devices, thereby enhancing patient safety and improving blood collection efficiency. The adoption of such advanced technology ensures that the market remains on a progressive growth curve. #### **Growth in Outpatient and Home Healthcare Settings** The trend towards outpatient and home healthcare services in the United States is significantly impacting the US Venous Blood Collection Devices Market Industry. The US Department of Health and Human Services reports that outpatient services have increased as part of a broader effort to decongest hospitals. This has led to a rise in the need for at-home blood collection solutions, especially among elderly patients and those with chronic conditions. Convenient blood collection options and the availability of devices that are easy to use in non-traditional settings contribute to this trend. Medtronic, one of the leading healthcare technology companies, has introduced home-use blood collection systems, catering to this growing demand and enhancing patient care, thus driving market growth. #### **Increasing Demand for Diagnostic Testing** The growing demand for diagnostic testing across various medical fields is a significant driver for the US Venous Blood Collection Devices Market Industry. The recent emphasis on early diagnosis and preventive healthcare has led to increased blood tests for various medical evaluations. According to the American Clinical Laboratory Association, the number of laboratory tests conducted annually is expected to rise, projecting an increase of around 10% over the next decade. Companies like Quest Diagnostics are expanding their testing capabilities and accessibility, fueling the growth in demand for blood collection devices. The necessity for accurate and timely diagnostic testing is crucial as it plays a vital role in effective healthcare delivery, thereby positively impacting the market. ## **US Venous Blood Collection Devices Market Segment Insights** ### **Venous Blood Collection Devices Market Type Insights** The US Venous Blood Collection Devices Market is primarily segmented by Type, with notable categories including Blood Collection Tubes and Lancets. Blood Collection Tubes play a critical role in the medical field as they are utilized for collecting blood specimens for various laboratory tests, making them essential for diagnostics. These tubes are designed to ensure the safe collection, transportation, and storage of blood samples, with various additives and coatings available depending on the intended laboratory analysis. As laboratories and healthcare providers increasingly prioritize efficiency and safety in blood sampling, the demand for innovative Blood Collection Tubes has significantly increased. On the other hand, Lancets, which are small, sharp devices used to puncture the skin to obtain blood, are also vital in various medical procedures, particularly for diabetes management and point-of-care testing. Their ease of use and ability to provide quick blood samples contribute to their significance in the market. Both segments are influenced by ongoing advancements in technology and manufacturing, which drive the development of user-friendly and safer devices. Furthermore, growing awareness regarding bloodborne diseases and the importance of safe blood collection practices are propelling the demand for high-quality Blood Collection Tubes and Lancets in the US. Regulatory requirements and healthcare compliance standards also push manufacturers toward innovation, fostering a competitive market that emphasizes quality, safety, and effectiveness. This focus on improving patient outcomes and the shift toward more automated and efficient blood collection methods are anticipated to enhance the growth of these segments within the US Venous Blood Collection Devices Market, as stakeholders strive to meet the rising needs of a rapidly evolving healthcare industry. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Venous Blood Collection Devices Market Material Insights** The US Venous Blood Collection Devices Market is primarily segmented by Material, with significant components including Plastic, Glass, and Steel. The growing demand for venous blood collection devices in the United States has led to an increased focus on the materials used in their production. Plastic is increasingly favored due to its safety, cost-effectiveness, and flexibility in design, which facilitates manufacturing and handling. Glass, while traditional, remains an option for its inert properties, allowing for more accurate testing results as it reduces the risk of chemical interactions. Steel is also considered for certain applications due to its durability and strength, especially in specialized devices. Each material plays a crucial role in ensuring sterilization, patient safety, and accurate diagnostics. The growing emphasis on safety regulations and technological advancements is expected to further influence the material selection in this market. Moreover, the ongoing shifts towards disposable products to enhance infection control practices bolster the prominence of plastics. As the US healthcare system evolves, adaptability in material usage will be instrumental in meeting the challenges posed by emerging healthcare trends and sustainability objectives. ### **Venous Blood Collection Devices Market Application Insights** The Application segment of the US Venous Blood Collection Devices Market encompasses various critical uses, with Vein Blood Gas Sampling being one of the prominent areas. This segment plays a significant role in assessing respiratory and metabolic functions, making it crucial for timely diagnosis and treatment in clinical settings. Due to the increasing prevalence of chronic respiratory diseases and the rising demand for accurate blood gas analysis, Vein Blood Gas Sampling has emerged as a major application in the healthcare sector. The efficiency of this sampling method allows healthcare professionals to obtain rapid results, facilitating prompt patient care. Moreover, advancements in technology are enhancing the reliability and safety of blood collection, contributing to its growing adoption in hospitals and laboratories. With the increasing focus on patient-centered care and the emphasis on quick decision-making in medical environments, this segment is positioned to play a vital role in the US healthcare industry, which is continuously evolving to meet the needs of patients and healthcare providers alike. As the market expands, it is expected that innovations and improvements in Venous Blood Collection Devices will further enhance the significance of Vein Blood Gas Sampling, ensuring it meets future healthcare demands effectively. ### **Venous Blood Collection Devices Market End User Insights** The US Venous Blood Collection Devices Market is significantly influenced by its End User segment, which primarily includes Hospitals and Blood Donation Centers. Hospitals are increasingly adopting advanced blood collection devices due to a rise in outpatient procedures and the need for efficient patient care management. These institutions often hold a majority share of the market due to their extensive patient base and continuous demand for precise diagnostic tests. On the other hand, Blood Donation Centers serve a vital role in ensuring a steady supply of blood for transfusions and medical emergencies, thereby fostering a crucial connection between donors and recipients. The focus on safety, accuracy, and innovation in these centers directly drives the adoption of new collection technologies. Overall, the End User segment plays a fundamental role in shaping the dynamics of the US Venous Blood Collection Devices Market, reflecting broader trends in healthcare delivery and blood management practices throughout the region. Factors such as regulatory standards, the emphasis on patient safety, and the increasing prevalence of chronic diseases contribute to the ongoing evolution of this segment. ## **US Venous Blood Collection Devices Market Key Players and Competitive Insights** The US Venous Blood Collection Devices Market is characterized by a dynamic competitive landscape, driven by technological advancements, increasing healthcare demands, and a focus on patient safety. Manufacturers within this market are actively engaged in product development, innovation, and strategic collaborations to enhance their market presence. The competitive insights reflect a blend of established companies and emerging players, each vying for market share by offering various blood collection products that cater to diverse medical needs. As healthcare providers demand more efficient and safer solutions for venous blood collection, the competition is expected to intensify, with players focusing on superior product features, compliance with regulatory standards, and customer service excellence. Terumo Medical Corporation has established a significant presence in the US Venous Blood Collection Devices Market, known for its innovative products and commitment to quality. The company's strengths lie in its extensive product portfolio, which includes various blood collection systems designed to enhance efficiency and safety. Terumo Medical Corporation's ability to leverage its advanced research and development capabilities allows it to regularly introduce new technologies that meet the evolving needs of healthcare providers. Its strong focus on customer relationships and education further solidifies its market position, making it a preferred choice among healthcare professionals in the venous blood collection segment. Hong Kong Balsa operates within the US Venous Blood Collection Devices Market with an emphasis on providing affordable and high-quality blood collection solutions. The company's key products include various types of blood collection tubes, safety needles, and accessories, all designed to enhance the convenience and safety of blood collection procedures. Hong Kong Balsa has built a reputation for innovation and reliability, helping it to strengthen its market presence in the US. The company’s commitment to maintaining competitive pricing while ensuring the highest safety standards is a distinct advantage. Furthermore, Hong Kong Balsa has explored strategic partnerships and mergers to expand its product offerings and enhance distribution capabilities within the US, enabling it to cater effectively to the growing demand in this sector. ### **Key Companies in the US Venous Blood Collection Devices Market Include** ### **US Venous Blood Collection Devices Market Industry Developments** The US Venous Blood Collection Devices Market has witnessed notable developments recently, particularly surrounding major companies like Terumo Medical Corporation, Abbott Laboratories, and Becton Dickinson and Company. In September 2023, Abbott Laboratories expanded its product range with innovative blood collection systems aimed at enhancing patient comfort and streamlining laboratory workflows. Simultaneously, Terumo Medical Corporation announced advancements in their blood collection technologies, emphasizing automation and efficiency within clinical settings. In the mergers and acquisitions sector, Smiths Medical has been in discussions for a strategic partnership with Medtronic to enhance their distribution capabilities, which is expected to finalize by the end of 2023, highlighting a growing collaboration trend within the industry. The market valuation of key players like Becton Dickinson has seen substantial growth, following increased demand fueled by the rise in diagnostic testing and outpatient procedures facilitated by regulatory support for faster approval of medical devices. The increase in market interest reflects a broader trend observed over the last two years, driven by innovations and a rising focus on enhancing patient outcomes. These developments illustrate a dynamic landscape in the US Venous Blood Collection Devices Market, characterized by technological advancements and strategic partnerships. ## **US Venous Blood Collection Devices Market Segmentation Insights** ### **Venous Blood Collection Devices Market Type Outlook** ### **Venous Blood Collection Devices Market Material Outlook** ### **Venous Blood Collection Devices Market Application Outlook** ### **Venous Blood Collection Devices Market End User Outlook** ## Market Drivers ### Increasing Focus on Patient Safety Patient safety remains a paramount concern in healthcare, significantly impacting the venous blood-collection-devices market. The emphasis on reducing hospital-acquired infections and ensuring safe blood collection practices has led to the development of advanced blood-collection devices. Regulatory bodies are increasingly mandating the use of safety-engineered devices, which are designed to minimize risks associated with blood collection. This trend is reflected in the market, where safety-engineered devices are projected to account for over 30% of total sales by 2026. Furthermore, healthcare institutions are investing in training programs to educate staff on best practices for blood collection, further enhancing patient safety. As a result, the focus on patient safety is likely to drive innovation and growth within the venous blood-collection-devices market. ### Rising Demand for Diagnostic Testing The venous blood-collection-devices market experiences a notable surge in demand due to the increasing prevalence of chronic diseases and the need for regular diagnostic testing. As healthcare providers emphasize early detection and preventive care, the utilization of blood tests has become more prevalent. According to recent data, the diagnostic testing market is projected to grow at a CAGR of approximately 6.5% through 2027. This growth directly influences the venous blood-collection-devices market, as more tests necessitate efficient and reliable blood collection methods. Furthermore, the expansion of outpatient services and home healthcare is likely to drive the demand for user-friendly blood-collection devices, enhancing patient comfort and compliance. Thus, the rising demand for diagnostic testing significantly propels the growth of the venous blood-collection-devices market. ### Expansion of Home Healthcare Services The expansion of home healthcare services is reshaping the landscape of the venous blood-collection-devices market. With an increasing number of patients opting for home-based care, there is a growing need for portable and easy-to-use blood-collection devices. This trend is particularly relevant for patients with chronic conditions who require regular monitoring. The home healthcare market is anticipated to grow at a CAGR of approximately 7% through 2028, indicating a substantial opportunity for manufacturers of venous blood-collection devices. Additionally, the convenience of home testing is likely to enhance patient compliance and satisfaction. As healthcare systems adapt to this shift, the demand for innovative blood-collection solutions tailored for home use is expected to rise, thereby driving growth in the venous blood-collection-devices market. ### Technological Innovations in Blood Collection Technological advancements play a crucial role in shaping the venous blood-collection-devices market. Innovations such as automated blood collection systems, safety-engineered devices, and advanced materials are enhancing the efficiency and safety of blood collection procedures. For instance, the introduction of devices that minimize the risk of needlestick injuries has become increasingly important in clinical settings. The market for safety-engineered devices is expected to witness a growth rate of around 8% annually, reflecting the industry's commitment to improving safety standards. Additionally, the integration of digital technologies, such as mobile applications for tracking blood collection, is likely to enhance user experience and streamline workflows. These technological innovations not only improve the quality of care but also contribute to the overall growth of the venous blood-collection-devices market. ### Regulatory Changes and Compliance Requirements Regulatory changes and compliance requirements significantly influence the venous blood-collection-devices market. As healthcare regulations evolve, manufacturers must adapt their products to meet new standards, which can drive innovation and improve device safety. The FDA and other regulatory bodies are continuously updating guidelines related to blood collection devices, emphasizing the need for safety and efficacy. Compliance with these regulations is essential for market entry and can impact product development timelines. Moreover, the increasing scrutiny on medical devices is likely to encourage manufacturers to invest in research and development to ensure their products meet the latest standards. Consequently, regulatory changes may create both challenges and opportunities within the venous blood-collection-devices market. ## Future Outlook the [Venous Blood Collection Devices Market](https://www.marketresearchfuture.com/reports/venous-blood-collection-devices-market-5761) is projected to grow at a 4.06% CAGR from 2025 to 2035., driven by technological advancements and increasing healthcare demands. **New opportunities:** - Development of smart blood-collection devices with integrated data analytics capabilities. - Expansion of mobile blood-collection units for remote patient access. - Partnerships with telehealth platforms to streamline blood-testing services. By 2035, the market is expected to achieve substantial growth, driven by innovation and strategic partnerships. ## Segment Insights ### By Type: Blood Collection Tubes (Largest) vs. Needles (Fastest-Growing) The segment distribution within the US venous blood-collection-devices market shows a significant preference for blood collection tubes, which dominate the landscape due to their widespread use and clinical importance. Needles are gaining traction in the market, reflecting a steady share as healthcare practices evolve towards safer and more efficient blood collection methods. Growth trends indicate that while blood collection tubes remain the largest segment, needles are emerging as the fastest-growing category due to advancements in needle technology aimed at improving patient comfort and reducing the risk of needlestick injuries. Other segment values like vacuum blood collection systems and microfluidic systems are also pivotal, but their growth is comparatively stable in the face of increasing demand for innovative solutions in diagnostics. Blood Collection Tubes (Dominant) vs. Needles (Emerging) Blood collection tubes are characterized by their critical role in specimen collection, influencing many diagnostic processes. They come in various sizes and contain different additives, making them versatile for diverse tests. In contrast, needles, while traditionally viewed as ancillary, are witnessing an evolution with innovations that enhance usability and safety. The emergence of safety-engineered needles aims to address the growing concerns over infection control, positioning them to capture a more significant market share as healthcare providers prioritize safety along with efficacy. The competition among these segments is intensifying, underscoring their respective significance within the US venous blood-collection-devices market. ### By Material: Plastic (Largest) vs. Glass (Fastest-Growing) In the US venous blood-collection-devices market, the distribution of market share among materials reflects distinct preferences in the industry. Plastic currently holds the largest share due to its lightweight and cost-effective nature, making it a favored choice among healthcare providers. Glass, while less prevalent, is gaining traction due to its superior containment properties, contributing to its status as a growing segment. Plastic (Dominant) vs. Glass (Emerging) Plastic, as the dominant material in the US venous blood-collection-devices market, is widely chosen for its durability and ease of use, catering to the increasing demand for reliable blood collection. It offers advantages like lower weight and reduced breakage risks compared to glass, positioning it as the preferred option in many healthcare settings. On the other hand, glass is emerging as a significant player due to its inert nature, which minimizes contamination risks and preserves sample integrity. As laboratories prioritize accuracy and reliability, glass is witnessing a renaissance in interest, especially in specialized applications where contamination is a critical concern. ### By Application: Vein Blood Gas Sampling (Largest) vs. Intraoperative Blood Salvage (Fastest-Growing) In the US venous blood-collection-devices market, the application segment is primarily dominated by vein blood gas sampling, capturing significant market share due to its widespread utilization in critical care settings. Intraoperative blood salvage is gaining traction, presenting a noteworthy alternative as surgical procedures frequently employ it. Both applications cater to specific clinical needs, contributing to their respective shares in the market. The growth trends in the application segment indicate a strong preference for vein blood gas sampling driven by increasing awareness about its advantages in patient monitoring and treatment. Meanwhile, intraoperative blood salvage experiences rapid growth as healthcare facilities focus on minimizing blood loss during surgeries and enhancing patient recovery times. This dual approach aligns with evolving healthcare practices and technological innovations, fostering continued investment in these blood-collection applications. Application: Vein Blood Gas Sampling (Dominant) vs. Intraoperative Blood Salvage (Emerging) Vein blood gas sampling is recognized as the dominant application within the US venous blood-collection-devices market, showcasing its significance in critical and emergency care. Its ability to provide rapid and accurate diagnostic information makes it indispensable in hospital settings. On the other hand, intraoperative blood salvage is emerging as a viable alternative, particularly in surgical environments. Its appeal lies in the capability to recycle blood lost during procedures, thereby reducing the need for transfusions and improving patient outcomes. This shift towards blood conservation practices is propelling intraoperative blood salvage into the spotlight, catering to the growing demand for effective and safe surgical solutions. ### By End-User: Hospitals and Clinics (Largest) vs. Point of Care (Fastest-Growing) The distribution of market share within the end-user segment of the US venous blood-collection-devices market reveals that hospitals and clinics hold the largest share, leveraging their extensive infrastructure and high patient turnover for efficient blood collection. Additionally, blood donation centers and diagnostic centers occupy significant portions, indicating a robust demand for venous blood collection in both therapeutic and diagnostic applications. Point of care, while smaller in share, is rapidly expanding as a segment, indicating a shift towards more convenient and immediate testing options. Growth trends are propelled by an increasing emphasis on early disease detection and the convenience of blood collection in non-hospital settings. The rapid integration of technology in point-of-care devices is driving innovation, while heightened awareness about the importance of diagnostics in preventive healthcare is benefiting hospitals and clinics. Moreover, demographic shifts, including an aging population, are catalyzing the demand for efficient blood collection solutions across all end-user sectors. Hospitals and Clinics (Dominant) vs. Point of Care (Emerging) Hospitals and clinics represent a dominant segment in the US venous blood-collection-devices market, characterized by high-volume procedures and a foundational role in patient care. These facilities benefit from established protocols for blood collection and robust patient networks, ensuring steady demand. On the other hand, the point of care segment is emerging as a significant player, attracting interest due to its ability to provide immediate diagnostic results. This emerging segment is marked by innovations in technology, which facilitate bedside testing and enable quicker clinical decision-making, catering to modern healthcare demands. The strategic focus on enhancing patient experience and reducing wait times further fuels the growth potential of point of care, making it a complementary counterpart to traditional hospital settings. ## Competitive Benchmarking The venous blood-collection-devices market is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and a focus on operational efficiency. Key players such as Becton Dickinson and Company (US), Terumo Corporation (JP), and Cardinal Health Inc. (US) are at the forefront of this dynamic environment. Becton Dickinson and Company (US) emphasizes innovation in product development, particularly in safety-engineered devices, which aligns with the growing demand for enhanced patient safety. Terumo Corporation (JP) focuses on expanding its product portfolio through strategic acquisitions, thereby enhancing its market presence. Cardinal Health Inc. (US) is actively pursuing digital transformation initiatives to streamline operations and improve customer engagement, which collectively influences the competitive dynamics of the market.The business tactics employed by these companies include localizing manufacturing and optimizing supply chains to enhance responsiveness to market demands. The market structure appears moderately fragmented, with several players vying for market share. However, the collective influence of major companies like Becton Dickinson and Cardinal Health creates a competitive environment where innovation and operational excellence are paramount. In October Becton Dickinson and Company (US) announced the launch of a new line of advanced blood collection devices designed to minimize patient discomfort and enhance safety. This strategic move is significant as it not only addresses the growing consumer demand for safer and more comfortable medical procedures but also reinforces Becton Dickinson's commitment to innovation in the healthcare sector. In September Terumo Corporation (JP) completed the acquisition of a regional competitor, which is expected to bolster its market position in the US. This acquisition is strategically important as it allows Terumo to expand its distribution network and enhance its product offerings, thereby increasing its competitive edge in a rapidly evolving market. In August Cardinal Health Inc. (US) launched a new digital platform aimed at improving supply chain transparency and efficiency. This initiative is crucial as it reflects the growing trend towards digitalization in the healthcare sector, enabling Cardinal Health to better meet customer needs and streamline operations. As of November the competitive trends in the venous blood-collection-devices market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI). Strategic alliances among key players are shaping the landscape, fostering innovation and enhancing product offerings. The shift from price-based competition to a focus on technological advancement and supply chain reliability is evident, suggesting that future competitive differentiation will hinge on the ability to innovate and adapt to changing market demands. ## Recent News & Developments The US Venous Blood Collection Devices Market has witnessed notable developments recently, particularly surrounding major companies like Terumo Medical Corporation, Abbott Laboratories, and Becton Dickinson and Company. In September 2023, Abbott Laboratories expanded its product range with innovative blood collection systems aimed at enhancing patient comfort and streamlining laboratory workflows. Simultaneously, Terumo Medical Corporation announced advancements in their blood collection technologies, emphasizing automation and efficiency within clinical settings. In the mergers and acquisitions sector, Smiths Medical has been in discussions for a strategic partnership with Medtronic to enhance their distribution capabilities, which is expected to finalize by the end of 2023, highlighting a growing collaboration trend within the industry. The market valuation of key players like Becton Dickinson has seen substantial growth, following increased demand fueled by the rise in diagnostic testing and outpatient procedures facilitated by regulatory support for faster approval of medical devices. The increase in market interest reflects a broader trend observed over the last two years, driven by innovations and a rising focus on enhancing patient outcomes. These developments illustrate a dynamic landscape in the US Venous Blood Collection Devices Market, characterized by technological advancements and strategic partnerships. ## Report Scope | MARKET SIZE 2024 | 1519.0(USD Million) | | --- | --- | | MARKET SIZE 2025 | 1580.67(USD Million) | | MARKET SIZE 2035 | 2353.22(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 4.06% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Becton Dickinson and Company (US), Terumo Corporation (JP), F. Hoffmann-La Roche Ltd (CH), Greiner Bio-One International GmbH (AT), Cardinal Health Inc. (US), Smiths Medical (US), Sarstedt AG & Co. (DE), Medtronic plc (IE) | | Segments Covered | Type, Material, Application, End-User | | Key Market Opportunities | Integration of advanced automation and safety features in venous blood-collection-devices market presents substantial growth potential. | | Key Market Dynamics | Technological advancements and regulatory changes drive innovation in the venous blood-collection-devices market. | | Countries Covered | US | ## Frequently Asked Questions **Q: What is the projected market valuation for the US venous blood-collection-devices market in 2035?** A: The projected market valuation for the US venous blood-collection-devices market in 2035 is $2353.22 Million. **Q: What was the overall market valuation for the US venous blood-collection-devices market in 2024?** A: The overall market valuation for the US venous blood-collection-devices market in 2024 was $1519.0 Million. **Q: What is the expected CAGR for the US venous blood-collection-devices market during the forecast period 2025 - 2035?** A: The expected CAGR for the US venous blood-collection-devices market during the forecast period 2025 - 2035 is 4.06%. **Q: Which segment had the highest valuation in the US venous blood-collection-devices market in 2024?** A: The vacuum blood collection system segment had the highest valuation in the US venous blood-collection-devices market in 2024, valued at $400.0 Million. **Q: What are the key players in the US venous blood-collection-devices market?** A: Key players in the US venous blood-collection-devices market include Becton Dickinson and Company, Terumo Corporation, and F. Hoffmann-La Roche Ltd. **Q: What is the valuation range for blood collection tubes in the US venous blood-collection-devices market?** A: The valuation range for blood collection tubes in the US venous blood-collection-devices market is $300.0 Million to $480.0 Million. **Q: Which material segment is expected to dominate the US venous blood-collection-devices market?** A: The plastic material segment is expected to dominate the US venous blood-collection-devices market, with a valuation range of $600.0 Million to $950.0 Million. **Q: What is the valuation for intraoperative blood salvage applications in the US venous blood-collection-devices market?** A: The valuation for intraoperative blood salvage applications in the US venous blood-collection-devices market is projected to be between $911.4 Million and $1403.22 Million. **Q: Which end-user segment is anticipated to have the highest valuation in the US venous blood-collection-devices market?** A: The hospitals and clinics end-user segment is anticipated to have the highest valuation in the US venous blood-collection-devices market, ranging from $600.0 Million to $950.0 Million. **Q: What is the valuation range for warming devices in the US venous blood-collection-devices market?** A: The valuation range for warming devices in the US venous blood-collection-devices market is between $30.0 Million and $50.0 Million. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-venous-blood-collection-devices-market-19558*